InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,300.34
(
-0.08%
)
US TECH 100
18,297.60
(
-0.11%
)
Dow Jones
38,928.62
(
-0.36%
)
Brent Oil
83.27
(
0.51%
)
Bitcoin
67,590.84
(
-2.60%
)

Replies to post #1761 on Cassava Sciences Inc (SAVA)

Replies to #1761 on Cassava Sciences Inc (SAVA)

runncoach

03/24/21 7:26 PM

#1762 RE: blue finch #1761

Nope, not at all. The Anavex peer reviewed and published data shows 2 out of the original 32 patients improved. After 15 weeks, 17 of the remaining 21 began the common descent downwards below baseline.